SFPM VIRTUAL MONTHLY SEMINARS

The Functional Precision Medicine Seminar, brought to you by the Members of SFPM, is a monthly series dedicated to showcasing advances in functional assays and their application in oncology precision medicine

Functional assays are in the truest sense precision medicine; matching a patient to a drug by directly testing their live tissue. The hypothesis is simple, yet in a personalized healthcare approach dominated by population scale genomics, the utilization of functional assays is limited. There exists a great opportunity to expand precision medicine beyond genomics, ultimately bringing better treatment options and the potential for greater outcomes to patients in need.

Bringing together a unique mix of pharmaceutical, academic and technology leaders, the series is must attend for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.

Through guest speakers, interactive panel discussions and Q&A sessions, the series will focus on these key topics:

  • Demonstrating the clinical utility of functional precision medicine testing
  • Implementing functional testing in precision medicine clinical trials
  • Accelerating the application of functional testing
  • Addressing stakeholder, educational and investment challenges for functional precision medicine

The SfPM arose out of recognition of the unmet need in matching cancer patients to the therapies best suited for them. Through the use of functional assays, we hope to bridge the gap between patients and the treatments best suited for their cancer. This is possible through research, communication, and collaboration amongst our members and with outreach to the cancer therapy community as a whole. Become a Member  today!

Members in good standing have access to our back catalog of seminar recordings .

Zoom Information

https://dfci.zoom.us

Meeting ID: 936 9981 1786
Password: 351904

If joining by phone:

  • +1 929 205 6099 US (New York)
  • +1 312 626 6799 US (Chicago)
  • +1 669 900 6833 US (San Jose)

  Register


Upcoming Speakers

December 8, 2021.

Dr Ameen Salahudeen
Dr Ameen Salahudeen

“”



Past Speakers

Bree Aldridge, PhD
Bree Aldridge, PhD
Tufts University

“Design of multidrug therapies for M. tuberculosis”


Diana Azzam, PhD
Diana Azzam, PhD
Robert Stempel College of Public Health & Social Work

“Clinical Utility of Functional Precision Medicine in the Management of Relapsed/Refractory Childhood Cancers”


Santhosh Balasubramanian
Santhosh Balasubramanian
Notable Labs

“Designing precision oncology trials to develop and validate drug sensitivity assays”


David A. Barbie, MD
David A. Barbie, MD
Dana-Farber Cancer Institute

“RNA Sequencing Analysis of Immunotherapy Response in Organotypic Tumor Spheroids”


Patrick Bhola, PhD
Patrick Bhola, PhD
Dana-Farber Cancer Institute

“Rapid ex vivo testing using high content dynamic BH3 profiling may identify active therapies in solid tumors”


Lawrence Boise, PhD
Lawrence Boise, PhD
Emory University

“Functional and phenotypic analysis of venetoclax sensitivity in multiple myeloma”


Jean-Philippe Coppé, PhD
Jean-Philippe Coppé, PhD
UC San Francisco

“Transformative kinase-activity mapping system to illuminate the phospho-catalytic dependencies and actionable vulnerabilities of therapy-resistant tumors”


Caroline Heckman, PhD
Caroline Heckman, PhD
Institute for Molecular Medicine

“Predicting drug combination efficacy in hematological malignancies by multi-parametric functional analysis”


Sarah J. Hill, MD, PhD
Sarah J. Hill, MD, PhD
Dana-Farber Cancer Institute

“Studying the anti-tumor immune response in novel patient-derived high grade serous ovarian cancer organoid co-cultures”


Peter J Houghton, PhD
Peter J Houghton, PhD
UT Health, San Antonio

“Single Mouse Testing (SMT) Approaches to Encompass Clinical Heterogeneity of Pediatric Cancers”


Olli Kallioniemi
Olli Kallioniemi
Karolinska Institute

“Functional precision cancer medicine: molecular insights and clinical implementation in AML and beyond”


Rich Klinghoffer, PhD
Rich Klinghoffer, PhD
Presage

“Intratumoral microdosing: Bridging the translational gap in cancer drug development and future potential as a functional diagnostic”


Razelle Kurzrock, MD
Razelle Kurzrock, MD
UC San Diego

“Precision Medicine: Implementing N-of-1 combination therapies in the clinic”


Ines Lohse, PhD
Ines Lohse, PhD
University of Miami

“Drug Sensitivity Testing for the Treatment Stratification of Cancer Patients”


Scott Manalis, PhD
Scott Manalis, PhD
Massachusetts Institute of Technology

“Single-cell mass as a clinical tool for guiding treatment decisions”


Astrid Margossian, MD, PhD
Astrid Margossian, MD, PhD
SEngine Precision Medicine

“Predictive Clinical Value of a CLIA-Approved Organoid Based Drug Sensitivity Test”


Gordon Mills, MD, PhD
Gordon Mills, MD, PhD
Oregon Health & Science University

“Novel approaches to identifying and targeting adaptive responses in cancer: PARP inhibitors as an example.”


Päivi Östling, PhD
Päivi Östling, PhD
SciLifeLab, Karolinska Institutet

“New host targets for fighting SARS-Cov2 infection”


Vinayak Prasad, MD, MPH
Vinayak Prasad, MD, MPH
University of California, San Francisco

“The Limits of Genome Oncology”


Julio Saez-Rodriquez, PhD
Julio Saez-Rodriquez, PhD
University of Heidelberg, Germany

“Patient‐specific network models from screenings on biopsies for personalized medicine”


Rosalie Sears, PhD
Rosalie Sears, PhD
Oregon Health & Science University

“Patient derived modeling to inform personalized therapeutics in pancreatic ductal adenocarcinoma”


Berend Snijder, PhD
Berend Snijder, PhD
ETH Zürich

“Pharmacoscopy: real-time drug response testing for blood cancers and solid tumors. ”


Philipp Staber, MD PhD
Philipp Staber, MD PhD
Medical University of Vienna

“Functional Precision Medicine for Patients with Hematologic Malignancies”


Louis M. Staudt, MD, PhD
Louis M. Staudt, MD, PhD
National Institues of Health

“The Use of Targeted Agents to Cure Lymphoma: Precision Medicine to Achieve Effective Medicine for All”


Hervé Tiriac, PhD
Hervé Tiriac, PhD
UCSD Moores Cancer Center

“Pancreatic Cancer Patient-Derived Organoids as a Tool for Personalized Medicine”


Gregory Vladimer, PhD, CSO
Gregory Vladimer, PhD, CSO
Allcyte

“High content microscopy of primary patient material and AI in translational research and precision medicine”


Alana L. Welm, PhD
Alana L. Welm, PhD
Huntsman Cancer Institute

“Functional precision medicine for metastatic breast cancer”


Thorsten Zenz, MD
Thorsten Zenz, MD
University of Zurich

“Drug-perturbation-based stratification of blood cancer”